Infertility affects nearly 20% of couples in reproductive age, and male factor of infertility is accountable for roughly half of the cases ([@r10]). Despite significant progress has been made in the diagnosis and treatment of male infertility, which allowed many men to have a biological child, the causes of many cases of male infertility are still unknown, thus hampering the use of tools to correct them.

The general semen quality seems to be deteriorating over time ([@r2]) and there are only so many things that can be done concerning the male factor of infertility. To date, the intracytoplasmic sperm injection (ICSI) is the treatment of choice for couples with male factor infertility, since the technique bypasses the sperm limitations related to the fertilization process and subsequent establishment of pregnancy. Nevertheless, according to recent studies, simple recommendations may favor the odds of pregnancy, such as shorter ejaculatory abstinence (EA) interval ([@r9]) and maternal endometrium exposure to paternal seminal plasma ([@r4]).

An EA interval of 2-7 days and 3-4 days prior to semen collection for conventional semen analysis has been recommended by the World Health Organization guidelines ([@r13]) and the European Society of Human Reproduction and Embryology ([@r7]), respectively. A recent study confirmed that an EA period of more than 7 days adversely impacts the outcomes, and that an abstinence of 2-4 days is associated with higher live-birth rates compared with periods of more than 7 days ([@r9]). In a study performed at out center, prolonged EA intervals had a detrimental effect on sperm function and quality. Despite longer EA intervals resulted in higher semen volume, sperm count, and total motile sperm count, they also increased sperm DNA fragmentation index and decreased fertilization, blastocyst formation rate, implantation rate and pregnancy rate. Additionally, the study established a cutoff point for EA length at 4 days (unpublished results). We postulated that shortening of EA intervals could optimize sperm quality by keeping epidydimal stasis at a minimum.

A recent meta-analysis of 2,204 patients in seven random controlled trials found a 23% improvement in clinical pregnancy rates when maternal endometria were exposed to seminal plasma around the time of oocyte retrieval or embryo transfer ([@r4]). Initially, seminal fluid, which is a cocktail complex cocktail of functionally diverse substances such as antioxidants, buffers, hormones, proteins and sugars, was simply presumed to facilitate sperm survival and delivery to the female reproductive tract. At present, the importance of these seminal fluid components as potential mediators of paternal-maternal communication has begun to be recognized ([@r5]).

Studies over the past two decades in both animal and human models showed that seminal plasma may positively affect endometrial receptivity, inducing an inflammation-like response, and thus promotes immune tolerance, facilitates implantation, and even positively influences offspring health ([@r1]; [@r12]; [@r6]; [@r11]). Previous studies showed that pregnancy outcomes are higher (i) after intravaginal administration of seminal plasma at embryo or gamete intrafallopian transfer (GIFT) ([@r1]), (ii) in couples that had sexual intercourse close to the time of human chorionic gonadotropin administration in GIFT cycles ([@r8]), (iii) in women experiencing recurrent miscarriage with pessaries of donor seminal plasma ([@r3]), and (iv) after in vitro fertilization treatment (IVF) when couples have intercourse either just before or just after embryo transfer ([@r12]). Still, there are some points that need to be addressed in future works, such as whether there is a superior method of seminal fluid exposure (sexual intercourse or delivery of intravaginal, intracervical, or intrauterine administration), and whether the general recommendation to patients undergoing IVF treatment, which are regularly counseled to abstain from coital activity because intercourse may cause uterine contractions and impair embryo implantation, is outdated.

Shortening EA interval and maternal exposure to paternal seminal plasma may be considered potential approaches for improving ICSI outcomes. Data provided here are promising, but requires well-designed studies to evaluate effects on pregnancy in patients undergoing ICSI as a result of male factor of infertility, before routine incorporation into clinical practice.
